[go: up one dir, main page]

ECSP003464A - PHARMACEUTICAL COMPOSITION FOR USE IN THE TREATMENT OF STREPTOCOCCUS PNEUMONIAE INFECTIONS - Google Patents

PHARMACEUTICAL COMPOSITION FOR USE IN THE TREATMENT OF STREPTOCOCCUS PNEUMONIAE INFECTIONS

Info

Publication number
ECSP003464A
ECSP003464A ECSP003464A ECSP003464A EC SP003464 A ECSP003464 A EC SP003464A EC SP003464 A ECSP003464 A EC SP003464A EC SP003464 A ECSP003464 A EC SP003464A
Authority
EC
Ecuador
Prior art keywords
pharmaceutical composition
treatment
streptococcus pneumoniae
pneumoniae infections
prone
Prior art date
Application number
Other languages
Spanish (es)
Inventor
Thomas Reeves Parr
Margaret Mary Wasilewski
Michael Lee Zeckel
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed filed Critical
Priority to ECSP003464 priority Critical patent/ECSP003464A/en
Publication of ECSP003464A publication Critical patent/ECSP003464A/en

Links

Landscapes

  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)

Abstract

Se sumistra una composición farmacéutica para uso en la fabricación de un medicamento para ser usado en la prevención a largo plazo de S. Pneumoniae en individuso propensos, en la cual al menos una dosis mensual de NDISSAC -(4-(4-clorofenil)bencil A82846B, teicoplanina, o mezclas de las mismas, es administrada a un individuo propenso.A pharmaceutical composition is supplied for use in the manufacture of a medicament for use in the long-term prevention of S. pneumoniae in prone individuals, in which at least one monthly dose of NDISSAC - (4- (4-chlorophenyl) benzyl A82846B, teicoplanin, or mixtures thereof, is administered to a prone individual.

ECSP003464 2000-05-02 2000-05-02 PHARMACEUTICAL COMPOSITION FOR USE IN THE TREATMENT OF STREPTOCOCCUS PNEUMONIAE INFECTIONS ECSP003464A (en)

Priority Applications (1)

Application Number Priority Date Filing Date Title
ECSP003464 ECSP003464A (en) 2000-05-02 2000-05-02 PHARMACEUTICAL COMPOSITION FOR USE IN THE TREATMENT OF STREPTOCOCCUS PNEUMONIAE INFECTIONS

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
ECSP003464 ECSP003464A (en) 2000-05-02 2000-05-02 PHARMACEUTICAL COMPOSITION FOR USE IN THE TREATMENT OF STREPTOCOCCUS PNEUMONIAE INFECTIONS

Publications (1)

Publication Number Publication Date
ECSP003464A true ECSP003464A (en) 2000-12-19

Family

ID=42041091

Family Applications (1)

Application Number Title Priority Date Filing Date
ECSP003464 ECSP003464A (en) 2000-05-02 2000-05-02 PHARMACEUTICAL COMPOSITION FOR USE IN THE TREATMENT OF STREPTOCOCCUS PNEUMONIAE INFECTIONS

Country Status (1)

Country Link
EC (1) ECSP003464A (en)

Similar Documents

Publication Publication Date Title
ECSP045102A (en) Pharmaceutical formulation containing 3- (3-dimethylamino-1-ethyl-2-methyl-propyl) phenol and provides a delayed release of the active ingredient
ATE302616T1 (en) MEDICINAL COMPOSITIONS FOR ORAL APPLICATION WITH CONTROLLED RELEASE OF ACTIVE INGREDIENTS
BRPI0415649A (en) method for treating, preventing, modifying or administering pain and pharmaceutical composition
AR032556A1 (en) IMMEDIATE ACTION DRUG FOR THE TREATMENT OF SEXUAL DYSFUNCTION
BRPI0113331B8 (en) phenylalanine derivatives or their pharmaceutically acceptable salts, alpha 4 integrin antagonist, therapeutic agent or preventive agent for inflammatory diseases, and pharmaceutical composition
BR0014383A (en) Controlled release compositions comprising nimesulide
AR018862A1 (en) PHARMACEUTICAL FORMULATION OF PROLONGED RELEASE, IMPROVED FOR THE ORAL ADMINISTRATION OF NEFAZODONA OR A PHARMACEUTICALLY ACCEPTABLE SALT OF THE SAME; ORAL DOSAGE FORM THAT UNDERSTANDS AND USE OF SUCH FORMULATION TO PREPARE THE SUCH DOSAGE FORM
DE50203456D1 (en) DEUTERATED 3-PIPERIDINOPROPIOPHENONE AND MEDICAMENTS CONTAINING SUCH COMPOUNDS
AR034517A1 (en) PHARMACEUTICAL FORMULATION
BR0112847A (en) Use of a solid dosage form
EE200300064A (en) Pharmaceutical composition for the treatment and / or prevention of C. pneumoniae infections, organic composition and their use
ATE464878T1 (en) PHARMACEUTICAL COMPOSITION FOR NASAL USE OF FENTANYL
UY27416A1 (en) USE OF BIBN4096 IN COMBINATION WITH OTHER ANTIMIGRANOSE DRUGS FOR THE TREATMENT OF MIGRANA
BRPI0412430A (en) zot and zonulin receptor agonist polypeptide
SE0001916D0 (en) Novel formulation
AR048318A1 (en) ORAL MATRIX FORMULATIONS THAT INCLUDE LICARBAZEPINA
AR041573A1 (en) USE OF HYDROMIDAZOLONES FOR THE PREPARATION OF MEDICATIONS FOR CANINOS
ECSP003464A (en) PHARMACEUTICAL COMPOSITION FOR USE IN THE TREATMENT OF STREPTOCOCCUS PNEUMONIAE INFECTIONS
AR037496A1 (en) NOVEDOUS USE OF 2- [5- (4-FLUOROPHENYL) -3-PIRIDILMETILAMINOMETIL] -CROMANO AND ITS PHYSIOLOGICALLY ACCEPTABLE SALTS
BR0210632A (en) Parasitic disease treatment
HRP20080597T3 (en) Cancer combination therapy comprising azd2171 and zd1839
SE0000303D0 (en) Novel compounds
SV2002000065A (en) MONTHLY DOSE FOR THE TREATMENT OF INFECTIONS BY STREPTOCOCCUS PNEUMONIAE REF. X-12423
SE0203817D0 (en) New composition
AR045074A1 (en) USE OF CD164 SOLUBLE IN INFLAMMATORY AND AUTO-IMMUNE DISORDERS